The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
This company appears not to get much attention. I listened to the podcast from Mark Atkinson , and I have been invested at different times over the last 5 years in MWE. The company ticks a lot of boxes for me as an investor, but because it is an Israeli company listed on the LSE might cause many to approach with caution. However I am particularly positive about their involvement in Water Management. Having worked in Israel for many years ago, I was able to see at first hand, how the land was transformed into growing all sorts of fruits and vegetables. The fact that they have been developing systems which optimize water usage is significant. The contract with The Israeli Ministry of Defence is a solid income stream as well. I am also attracted to this company for it’s spread of risk in several in vogue technological developments with patents. MWE took a hit about this time last year, and the share price plummeted to a little below what it is currently trading at,- when the Russian business closed, but this only accounted for a small % of turnover, and has been easily made up. As a moderately adverse risk relatively small value investor, IMHO MWE is worth a punt. Only a small volume of shares can move the price quite considerably, with finals up in couple of weeks, and a dividend on offer, this should be a buy. Investors Chronicle continues to think so too. Stick with it!
The current drop in share price today before the results,-Could this be the result of the market makers undertaking a classic 'TREE SHAKE'? Although it appears most of the trades are sells, the total volume is still very small.
Hi, With so much positive news about SureServe, it was 'Sure' to pick up some momentum before the finals on 24th Jan. Hopefully it can reach the magic 100p before then. We will see?!
Most of the sells, are in fact buys. I made a purchase today sub 43, it is recorded as a sell. This company is progressing well, the recent acquisition should be earnings enhancing soon. My only concern is the high PE, but this company has always had a high PE.
At the current price, this has to be a buy. The graph shows close to lows last 12 months. All the news appears positive, the only negative might be that is an Israeli company.- but I think that is already factored into the price. IMHO
I believe Monday should be an interesting day in the markets, prior to results. Hopefully it will sustain, 100p buy and sell. There is much positive news about new contracts and recurring business. One to tuck away for a while, IMHO.
Bought a tranche yesterday, but registered as a SELL. This was amongst many other purchases at around the same price, also showing a SELL.
Volumes showing sells and buys yesterday should be reviewed with caution. As for the company, the big retreat on Monday, is baffling. As posted earlier my another member, it may have been 'marked down' because of the 'gas debacle'.- as we all know has nothing directly to do with SUR. Hopefully the share price will recover to 90p and above. Good Luck!
"Jam yesterday, jam tomorrow, but never jam today." This could well retrace to 3.75 in the coming weeks. IMHO
Buy at sub 60p, this IMHO is a Buying Opportunity. Although Sales to Buys of shares today are in the ratio of 3:1, the volume is very low. Sit tight, and top up. I will being doing this.
Back to Eve. Been in and out of EVE, recently, buys 3.8 and 4.0, then sold fortunately at 5.7. Holding off until after AGM, what are the chances of a Rights Issue being announced to fund increased advertising drive? How strong is this a possibility?
Interesting radio comment on R4 today- Your and Yours Monday 18th January. People working from home and from their beds! Lying in bed for increased hours, would surely assist the sale of Premium Mattrress Beds such as Eve. Looking forward to some positive progress with update on Thursday.